OpenBilldrug price receipt

NADAC week of 2026-10-14

VERAPAMIL ER 240 MG TABLET

For 30 tablets

Pharmacies pay

$5.28 filed

30 × $0.17613 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$10.20 filed

30 × $0.33995 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.9× estimated

Medicare paid 1.9× what pharmacies pay.

Part D averages every strength and form sold under “Verapamil ER” / “Verapamil HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$11.07 estimated

$5.28 + $0.79 (15%) + $5.00 fee per fill = $11.07

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

VERAPAMIL ER 240 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as verapamil hydrochloride.

FDA gives its dosage form as “tablet” and “tablet, film coated, extended release” and its route as oral.

Its labelers, the companies named on the label, are Zydus Pharmaceuticals (USA) Inc., Glenmark Pharmaceuticals Inc., USA and Nivagen Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is Calcium Channel Blocker.

The NADAC file of 2026-10-14 prices it under 6 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $5.28 for 30 tablets (30 × $0.17613 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

All 6 NDCs

Other strengths, forms and brands

15 other products in the NADAC file share the FDA nonproprietary name verapamil hydrochloride with VERAPAMIL ER 240 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
VERAPAMIL 40 MG TABLET
generic · tablet, film coated / tablet
$0.11259 per EA filed
eff. 2026-09-23
$0.10044 per EA filed
Part D 2024 average
VERAPAMIL 80 MG TABLET
generic · tablet, film coated / tablet
$0.07325 per EA filed
eff. 2026-09-23
$0.10044 per EA filed
Part D 2024 average
VERAPAMIL 120 MG TABLET
generic · tablet, film coated / tablet
$0.08873 per EA filed
eff. 2026-09-23
$0.10044 per EA filed
Part D 2024 average
VERAPAMIL ER 120 MG CAPSULE
generic · capsule, extended release
$2.74927 per EA filed
eff. 2026-09-23
$0.33995 per EA filed
Part D 2024 average
VERAPAMIL ER 120 MG TABLET
generic · tablet / tablet, film coated, extended release
$0.17779 per EA filed
eff. 2026-09-23
$0.33995 per EA filed
Part D 2024 average
VERAPAMIL ER 180 MG CAPSULE
generic · capsule, extended release
$2.08661 per EA filed
eff. 2026-09-23
$0.33995 per EA filed
Part D 2024 average
VERAPAMIL ER 180 MG TABLET
generic · tablet / tablet, film coated, extended release
$0.19107 per EA filed
eff. 2026-09-23
$0.33995 per EA filed
Part D 2024 average
VERAPAMIL ER 240 MG CAPSULE
generic · capsule, extended release
$3.1476 per EA filed
eff. 2026-09-23
$0.33995 per EA filed
Part D 2024 average
VERAPAMIL ER 240 MG TABLET this page
generic · tablet / tablet, film coated, extended release
$0.17613 per EA filed
eff. 2026-09-23
$0.33995 per EA filed
Part D 2024 average
VERAPAMIL ER PM 100 MG CAPSULE
generic · capsule, extended release
$4.08287 per EA filed
eff. 2026-09-23
$5.10337 per EA filed
Part D 2024 average
VERAPAMIL ER PM 200 MG CAPSULE
generic · capsule, extended release
$5.63549 per EA filed
eff. 2026-09-23
$5.10337 per EA filed
Part D 2024 average
VERAPAMIL ER PM 300 MG CAPSULE
generic · capsule, extended release
$7.92023 per EA filed
eff. 2026-09-23
$5.10337 per EA filed
Part D 2024 average
VERAPAMIL SR 120 MG CAPSULE
generic · capsule, delayed release
$2.74927 per EA filed
eff. 2026-09-23
We don’t know yet
VERAPAMIL SR 180 MG CAPSULE
generic · capsule, delayed release
$2.08661 per EA filed
eff. 2026-09-23
We don’t know yet
VERAPAMIL SR 240 MG CAPSULE
generic · capsule, delayed release
$3.1476 per EA filed
eff. 2026-09-23
We don’t know yet
VERAPAMIL SR 360 MG CAPSULE
generic · capsule, delayed release
$7.80238 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 6 NDCs’ NADAC prices is $0.17613 per EA filed.

Of the 107 other products in FDA’s Calcium Channel Blocker class priced per EA, 86 have a higher middle NADAC price and 21 a lower one. The one in the middle is DILTIAZEM 24H ER(LA) 240 MG TB, at $1.0087 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $10.20 for 30 tablets, at an average of $0.33995 per EA in 2024 (2024-01-01 to 2024-12-31) for “Verapamil ER” and “Verapamil HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 1,065,275 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for VERAPAMIL ER 240 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Verapamil ER / Verapamil HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.